Article Details

Nektar Therapeutics (NASDAQ:NKTR) Director Sells $151840.00 in Stock

Retrieved on: 2021-04-17 23:37:30

Tags for this article:

Click the tags to see associated articles and topics

Nektar Therapeutics (NASDAQ:NKTR) Director Sells $151840.00 in Stock. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 18,378,080 shares of the biopharmaceutical company's stock valued at $312,426,000 after buying an additional 401,898 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up